Who we are. 

Human Regenerative Technologies, LLC (HRT®) is a biologics company focused on advancing the understanding and development of human amniotic and placental properties through scientific and clinical application. Our product development team has over 50 years combined biologics experience. Our team’s research and development has enabled HRT® to emerge as a leader in natural human tissue allografts derived from amniotic membranes and placental connective tissues. HRT® continues to advance biologic technologies derived from the dynamic placental system, which provides the foundation of the body’s various tissues and organs.

HRT® is proud to be accredited by the American Association of Tissue Banks® (AATB).